These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4706921)

  • 1. Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
    Imura H; Nakai Y; Matsukura S; Matsuyama H
    Horm Metab Res; 1973 Jan; 5(1):41-5. PubMed ID: 4706921
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of human-growth-hormone secretion by L-dopa.
    Boyd AE; Lebovitz HE; Pfeiffer JB
    N Engl J Med; 1970 Dec; 283(26):1425-9. PubMed ID: 5481776
    [No Abstract]   [Full Text] [Related]  

  • 3. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
    Massara F; Camanni F; Molinatti GM
    Horm Metab Res; 1973 Nov; 5(6):454-6. PubMed ID: 4767002
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of L-dopa on plasma growth hormones and insulin.
    Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
    Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
    Kansal PC; Buse J; Talbert OR; Buse MG
    J Clin Endocrinol Metab; 1972 Jan; 34(1):99-105. PubMed ID: 5061778
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
    Sirtori CR; Bolme P; Azarnoff DL
    N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of L-dopa on pituitary hormones and on carbohydrate and fat metabolism in normal persons and in patients with Parkinsonism].
    Geser CA; Müller-Hess R; Dufresne JJ; Felber JP; Vannotti A
    Schweiz Med Wochenschr; 1973 May; 103(19):690-7. PubMed ID: 4703913
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma insulin levels in renal diabetes].
    Rosselin GE; Dérot M
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():341-58. PubMed ID: 5212266
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute metabolic studies with trasicor in diabetics.
    McKechnie JK; Goldman A; Vinik AI
    S Afr Med J; 1969 Dec; ():Suppl:24-6. PubMed ID: 4906673
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man.
    Jezová-Repceková D; Klimes I; Jurcovicová J; Vigas M
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):64-7. PubMed ID: 422303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of pizotifen treatment on growth hormone levels of underweight children, including those with anorexia nervosa.
    Dolecek R; Janstová V
    Pharmatherapeutica; 1985; 4(2):81-7. PubMed ID: 4059293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of blood insulin and growth hormone to glucose infusion in normal, psoriatic and diabetic persons.
    Hopsu-Havu VK; Terho PE; Vanha-Perttula TP; Viljanen MK
    Acta Derm Venereol; 1973; 53(1):39-44. PubMed ID: 4120806
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of insulin, glucagon and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa.
    Blickle JF; Reville P; Stephan F; Meyer P; Demangeat C; Sapin R
    Horm Metab Res; 1984 Jul; 16(7):336-40. PubMed ID: 6386641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phentolamine inhibition of human growth hormone secretion induced by L-DOPA.
    Cammani F; Massara F
    Horm Metab Res; 1972 Mar; 4(2):128. PubMed ID: 4554974
    [No Abstract]   [Full Text] [Related]  

  • 16. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F; Massara F; Molinatti GM
    Biomedicine; 1974 Jun; 21(6):241-3. PubMed ID: 4441586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J; Holmsen R
    Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of L-dopa and chlorpromazine on human growth hormone and TSH secretion in normal subjects and acromegalics.
    Singh P; McDevitt DG; Mackay J; Hadden DR
    Horm Res; 1973; 4(5):293-301. PubMed ID: 4755420
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of intravenous L-dopa on growth hormone and luteinizing hormone levels in man.
    Souvatzoglou A; von Werder K; Bottermann P
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):259-65. PubMed ID: 4740825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.